Hepatocellular carcinoma (HCC) mortality rates are increasing globally, and particularly in
the Western world. Cirrhosis remains the predominant risk factor for HCC. However …

Hepatocellular carcinoma (HCC) mortality remains high primarily due to late diagnosis as a
consequence of failed early detection. Professional societies recommend semi‐annual HCC …

This guidance document provides an updated approach to the prevention, diagnosis, and
treatment of hepatocellular carcinoma (HCC). The prior American Association for the Study …

Major research efforts in liver cancer have been devoted to increasing the efficacy and
effectiveness of surveillance for hepatocellular carcinoma (HCC). As with other cancers …

Hepatocellular carcinoma (HCC) is a leading cause of cancer‐related mortality worldwide.
Early detection of HCC enables patients to avail curative therapies that can improve patient …

Abstract Background & Aims We aimed to compare the performance of gadoxetic acid‐
enhanced abbreviated MRI (AMRI)‐based surveillance and ultrasound‐only surveillance in …

Background Microvascular invasion (MVI) is a critical risk factor for early recurrence of
hepatocellular carcinoma (HCC) and intrahepatic cholangiocarcinoma (ICC). The aim of this …

The hepatitis C virus (HCV), a single-stranded RNA virus belonging to the Flaviviridae
family, is a major cause of hepatocellular carcinoma (HCC) worldwide. Tumors caused by …

Hepatocellular carcinoma (HCC) is a major cause of death in many countries, including
South Korea. To provide useful and sensible advice for clinical management of patients with …

Hepatocellular carcinoma (HCC) is a leading cause of mortality worldwide and a major
healthcare burden in most societies. Computed tomography (CT) and magnetic resonance …